The role of resection for patients with renal carcinoma.

被引：6

作者：

Flanigan R.C. ^{[1
]}

Yonover P.M. ^{[1
]}

机构：

[1] Department of Urology, Cardinal Bernardin Cancer Center, Loyola University Medical Center, 2160 South First Avenue, Maywood, 60153, IL

来源：

Current Oncology Reports | 2001年 / 3卷 / 5期

关键词：

Renal Cell Carcinoma; Metastatic Renal Cell Carcinoma; Cytoreductive Nephrectomy; Metastatic Renal Cancer; Rapid Tumor Progression;

D O I：

10.1007/s11912-001-0029-0

中图分类号：

学科分类号：

摘要：

Metastatic renal cancer is responsive in some cases to immunotherapeutic agents. Indications for nephrectomy in the face of metastatic disease have traditionally included palliation of symptoms caused by the primary tumor, and nephrectomy combined with metastatectomy in patients with resectable metastases. Recent findings from a Southwest Oncology Group trial strongly suggest that cytoreductive nephrectomy, combined with immunotherapy, may also result in improved survival in patients with unresectable metastases.

引用

页码：424 / 432

页数：8

共 114 条

[51]

Tolia BM(undefined)undefined undefined undefined undefined-undefined

[52]

Whitmore WF(undefined)undefined undefined undefined undefined-undefined

[53]

deKernion JB(undefined)undefined undefined undefined undefined-undefined

[54]

Ramming KD(undefined)undefined undefined undefined undefined-undefined

[55]

Smith RB(undefined)undefined undefined undefined undefined-undefined

[56]

Kavolius JP(undefined)undefined undefined undefined undefined-undefined

[57]

Mastorakos DP(undefined)undefined undefined undefined undefined-undefined

[58]

Pavlovich C(undefined)undefined undefined undefined undefined-undefined

[59]

Fisher RI(undefined)undefined undefined undefined undefined-undefined

[60]

Coltman CA(undefined)undefined undefined undefined undefined-undefined

← 1 2 3 4 5 6 7 8 9 10 →